The Biopharmaceutical industry is experiencing growth and evolution with the integration of new systems and unique solutions to enhance outdated technologies. Global collaboration and cross-disciplinary expertise are essential to drive innovation and meaningful change. Bioreactor technology, particularly in perfusion and continuous processing, is a key priority for the industry's future – and automated feedback controls play a significant role in advancing biomanufacturing.
As a result of the growing demand for new drug products and therapies, the emergence of new processes, and the integration of new technologies, industry leaders are facing difficult decisions that may challenge their expertise and conventional thinking. We propose a panel discussion to assist individuals in approaching intersecting domains – such as equipment design, workforce development and (re)training, facility design choices, as well as logistics and procurement – in a holistic and principle driven manner.
Continuous and intensified processing has become a key focus in biologics manufacturing. This panel brings together industry experts to share real-world insights on current challenges and the future of continuous bioprocessing. Topics include unit operations development, integration of steps, automation strategies, and regulatory considerations. Each speaker offers a unique perspective, making this session a valuable overview of both the opportunities and risks of adopting continuous processes in biomanufacturing.
